Nordstrom, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$1.04B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: JWN stock price vs ORCL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Implied fair value · at JWN's multiple
Needs JWN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
17 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Nordstrom, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Oracle Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TJX COMPANIES INC /DE/
JWN vs TJX
ROSS STORES, INC.
JWN vs ROST
Macy's, Inc.
JWN vs M
KOHLS Corp
JWN vs KSS
Walmart Inc.
JWN vs WMT
COSTCO WHOLESALE CORP /NEW
JWN vs COST
Microsoft Corporation
JWN vs MSFT
Amazon.com, Inc.
JWN vs AMZN
Alphabet Inc.
JWN vs GOOGL
International Business Machines Corporation
JWN vs IBM
Cisco Systems, Inc.
JWN vs CSCO
Salesforce, Inc.
JWN vs CRM
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe JWN can sustain margin improvement and avoid leverage pressure despite only 2.2% revenue growth, then a selective long may be reasonable, but based on the current data ORCL’s ORCL benchmark does not justify aggressive upside in JWN.
On the provided ORCL framework, JWN’s implied price of $38.76 sits just below the low end of ORCL-implied range of $39.24 to $499.68 and inside the DCF range of $36.10 to $48.84. That suggests limited upside from the current setup and a valuation that is supported more by the DCF range than by the ORCL-based ORCL multiple lens.
Supporting Metrics